Is it being used the way it was approved

Claims tell you what was billed. Why the drug was chosen, and what happened before it was stopped, exists only in the clinician's own sentences.

Why it stays invisible

Real-world evidence needs two things: how many patients, and what happened to them. Claims data gives you the first and not the second.

Stopped for a side effect, tried another drug that did nothing, endoscopic grade was such-and-such — all of it sits in free text a clinician wrote. It does not reduce to a code, so it disappears from standardized datasets.

What we have actually found

Every number below came out of a live analysis session, and the session it came from is noted with it.

Fexuclue prescribed beyond the approved eight weeks: 47 instances across 21 patients. The longest ran 185 days.
Session 87abbbbc
Of 89 chart patients on the same drug, 85 were absent from claims.
Session e02c4876
Side-effect narratives were found at the term as written: 108 of 108 recall with prefix matching, zero false positives.
SPEC §7.3 search accuracy measurement

What you receive

One question, one document. Nobody rewrites it afterwards.

The question as you asked it
The patient count and the record excerpts behind it
What was matched, on which spelling, against which denominator
What this number cannot say — small cells, false positives removed
The questions we could not answer

Where the records were issued

This is not data obtained through a partnership. Each record was issued to the patient, by the hospital, at the patient's own request.

The 25 most requested. Records have come from 127 hospitals in all.

Common questions